Panel Discussion: From factory to patient – Just-in-time deliveries
The first panel discussion of the day, titled 'From factory to patient: Just-in-time deliveries,' brought together a powerhouse of…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Powering advanced therapies with specialised supply chain
One of the key individual sessions at the Pharma & Med Devices Supply Chain Summit 2025 explored how India’s pharma logistics…
Supplier Engagement / Negotiation Strategy
The session titled ‘Supplier Engagement / Negotiation Strategy’ at the Pharma & Med Devices Supply Chain Conclave 2025,was led…
Special Address
Archana Jatkar, Associate Secretary General, IPA began her address by highlighting the dynamic challenges confronting the global…
Shorter immunotherapy duration for advanced melanoma shows comparable disease control in UK DANTE…
UK-led phase III trial reports similar disease control at 12 months versus two years of immunotherapy for inoperable late-stage…
PLUSS Advanced Technologies and Ecodome Logistics unite to build India’s greenest, most reliable…
Partnership aims to reduce vaccine spoilage, cut carbon emissions, and improve temperature control in pharma logistics across…
EyePoint’s Duravyu holds potential to become new treatment option for wAMD: GlobalData
Sustained-release implant Duravyu may reduce treatment burden in wet AMD patients while maintaining efficacy and durability
Gland Pharma receives USFDA approval for Angiotensin II Acetate injection
Gland Pharma secures 180-day exclusivity for Angiotensin II Acetate Injection following USFDA approval
IGI reports phase 1 results of ISB 2001 trispecific antibody in relapsed or refractory multiple…
TRIgnite-1 study shows 79 per cent response rate and no dose-limiting toxicities in early-stage trial of BCMA × CD38 × CD3…
Sun Pharma ends development of SCD-044 after phase 2 trials fail to meet primary endpoints
SCD-044 trials for psoriasis and atopic dermatitis show no major safety concerns